Article Details

Nektar Therapeutics (NASDAQ:NKTR) Trading Down 3.4% Following Insider Selling

Retrieved on: 2025-08-23 12:54:36

Tags for this article:

Click the tags to see associated articles and topics

Nektar Therapeutics (NASDAQ:NKTR) Trading Down 3.4% Following Insider Selling. View article details on hiswai:

Excerpt

Acadian Asset Management LLC now owns 7,301,734 shares of the biopharmaceutical company's stock worth $4,961,000 after buying an additional 100,645 ...

Article found on: www.defenseworld.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo